Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Advanced Visualization| March 09, 2016

The Unsettling Evolution of Advanced Visualization

The Unsettling Evolution of Advanced Visualization

Browser-based enterprise viewing promises to bridge the gap between EMR and PACS. (Image courtesy of TeraRecon)

“You keep same-in’ when you ought to be a changin’ … One of these days these boots are gonna walk all over you.”

— “These boots are made for walking,” Nancy Sinatra

 

Where better for the wisdom of Nancy Sinatra to take root than in Las Vegas, site of this year’s HIMSS conference. There the evolution of advanced visualization was in plain and startling view.

A couple decades ago, advanced visualization was a complement to picture archiving and communication systems (PACS); software running on workstations and thin-client networks that did what PACS could not; a vehicle for delivering eye candy to radiologists willing to push back the frontier of medical visualization one new application at a time.

Back then, those workstations and thin-client networks looked like luxuries. They met the needs of only the elite of medical imaging. Their visualizations skirted the periphery of medicine — beautiful, but limited in their utility. It seemed all but inevitable, at least to me, that they would eventually become radiology’s equivalent of an ornate buggy whip, made obsolete inevitably by automobiles, one that despite its beauty was fated to go belly up. But it hasn’t. And it won’t. At least not any time soon.

Advanced visualization has reinvented itself. It survives as PACS fades, flourishing as the new sidekick to the successor of PACS, enterprise imaging.

The company once known as Vital Images, acquired several years ago by Toshiba and reborn as Vital, was busy at HIMSS 2016 carving out a new role for itself. It expanded on its visualization platform to offer interoperability spanning information systems across the enterprise. At the conference, Vital launched what the company described as a “personalized HIE/EMR viewing platform.”

Recognizing the inordinate — and growing — power of the C suite, Vital presented its new enterprise interoperability platform as “the CIO’s best friend.” Defined largely by what it does for healthcare, this platform was promoted as the means to better outcomes in accountable care, accomplishing this goal by providing common ground for electronic medical records, health information exchanges, VNAs and PACS.

It is, according to the company, a “personalized viewing platform,” a kind of “missing link.” Its toolkit, called “Vital Box,” is designed, says the company, for chief information officers and information technology vendors to integrate processes associated with electronic medical records and various multimedia sources, including VNAs and PACS.  As part of its mission, this platform supports a next generation “universal viewer” that provides access to traditional medical images contained in PACS, as well as other content, such as the multimedia files from disciplines outside radiology.

Also wedging itself at HIMSS 2016 into the gap between images and electronic medical records was TeraRecon, which not long ago was a pure play, thin-client provider of advanced visualization, offering renderings that stunningly eclipsed any that PACS could do. This was its special niche. But at HIMSS, TeraRecon introduced image sharing solutions that “support multiple workflow and user management scenarios.” Amid the TeraRecon portfolio was an enterprise viewer that could be configured to provide simple views as well as complex post-processed ones.

A major goal, according to the company, is to expedite the exchange of images among facilities, eliminating the need to send CDs bearing medical images. This image sharing includes options for exporting images to PACS, as well as the ability to distribute them across the enterprise, leveraging standards that go beyond DICOM, ones that cover cross-enterprise data exchanges. It includes the means for integrating these images with hospital enterprise user management systems so as to ensure, according to the company, easy and secure image exchange with specialists throughout an institution.

TeraRecon’s transformation has been in the works for a while. At HIMSS four years ago, the company highlighted efforts to image-enable the EMR using a scalable thin-client solution for processing and distributing images. Among its features was a zero-footprint, multimodality, browser-based enterprise viewer offering advanced image processing for radiological exams. At the core of these options then — and now — is interoperability, the ability to seamlessly integrate with EMR, the VNA, PACS and other healthcare information systems.

The transformation of these two companies is a sign of change in the world of medical imaging. It is certainly not the only such sign, but it is one that bears close attention, reflective of the new reality of value-based medicine and its demand that imaging play an increased role in both outcomes and fiscal responsibility.

In short, the comfortable surroundings sculpted by DICOM are giving way to the complex and multifaceted landscape of the image-enabled enterprise. It’s been a long time coming, but it’s picking up speed … and fast.

Radiology has two choices: adapt or be prepared, as Nancy sang, “to be walked all over.”

 

Editor’s note: This is the second blog in a series of four by industry consultant Greg Freiherr on MR Balances Speed and Clinical Reach. To read MR is About to Get Faster, Cheaper and More Valuable: It's About Time, click here.

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...